Gamma-aminobutyric acid receptors and hypothalamic-pituitary-adrenal axis components (GABA-HPA axis)

The interaction between Gamma-aminobutyric acid (GABA) receptors and the Hypothalamic-Pituitary-Adrenal (HPA) axis represents a critical regulatory system for the body's stress response [1]. GABA, the primary inhibitory neurotransmitter in the central nervous system, exerts a tonic inhibitory influence on the paraventricular nucleus (PVN) of the hypothalamus, thereby suppressing the release of Corticotropin-Releasing Hormone (CRH) [2][3]. Activation of the HPA axis involves a cascade where CRH stimulates the pituitary to release Adrenocorticotropic Hormone (ACTH), which in turn triggers the adrenal glands to produce glucocorticoids like cortisol [2]. Dysregulation of this inhibitory control—often characterized by reduced GABAergic tone or HPA axis hyperactivity—is a hallmark of various psychiatric and endocrine disorders, including anxiety, depression, and post-traumatic stress disorder (PTSD) [3][4]. Pharmacological intervention typically targets individual components, such as GABA-A receptors with benzodiazepines to enhance inhibition or glucocorticoid receptors to modulate feedback loops [1][5]. Understanding this system is vital for developing integrated treatments for stress-related pathologies.

Other names

GABA-HPA systemGABAergic regulation of the HPA axisGABA-HPA interactionGABAergic-HPA axis pathway

Positive allosteric modulation of GABA-A receptors; Agonism of GABA-B receptors; Antagonism or agonism of glucocorticoid receptors; Antagonism of corticotropin-releasing hormone (CRH) receptors.